Dallas Fort Worth Injury Lawyer Blog

July 30, 2015

Morcellator Hysterectomy and FDA Black Box Warnings

Power morcellators are medical devices used to allow surgeons to cut up and remove fibroids through a minimally invasive incision in the abdomen. Over the past 2 years, medical experts have questioned the safety of the devices, since some women may have undiagnosed cancers contained within the uterus, which the devices may rapidly spread throughout the body, during the grinding and cutting process.

FDA Black Box Warning for Power Morcellators

The FDA has hammered the laparoscopic power morcellator devices with the strongest warning possible, requiring the morcellators to have a black box warning concerning the risk of cancer spread.

July 13, 2015

Xarelto Bleeding Side Effects and Lawsuits Increasing

by Dr. Shezad Malik

Xarelto is under fire, if you follow the allegations in the over 550 lawsuits filed to date. Xarelto is one of the newer oral anticoagulant medications that has been approved by the FDA. The federal Xarelto personal injury and product liability claims are centralized before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana.

Xarelto is one of the newer oral anticoagulant medications that has been approved by the FDA.

Xarelto Personal Injury Bleeding and Death Cases Over 550

July 12, 2015

What is the problem with Power Morcellator Hysterectomy?

by Dr. Shezad Malik

Laparoscopic morcellator lawsuits are increasing slowly but surely, filed by injured women who had undiagnosed uterine cancer spread during a minimally invasive hysterectomy. Recently, according to the Wall Street Journal, a settlement has been reached in one of the first federal lawsuits.

Lina Medical reportedly has agreed to settle Scott Burkhart’s wrongful death claim of his wife, who had undiagnosed leiomyoscarcoma spread throughout her body by a Lina power morcellator.

Burkhart’s case was the first of several hysterectomy morcellation lawsuits, which allege that several different medical device manufacturers sold a defective and unreasonably dangerous product, and failed to warn about the serious risk of cancer women may face if the morcellator is used during a minimally invasive surgery.

July 11, 2015

Invokana Diabetes Drug Side Effects Lawsuits

by Dr. Shezad Malik

According to the FDA recent warning, there are serious issues and side effects with the new class of medications used to treat type 2 diabetes.

What is Invokana?

Johnson & Johnson’s Janssen Pharmaceuticals unit manufactures and distributes Invokana (canagliflozin), for patients with type-2 diabetes, to control their blood-sugar levels. The drug has achieved blockbuster status, in that it is set to blow past a billion dollars in sales in 2015.

July 10, 2015

Zimmer Persona Artificial Knees Under Fire

by Dr. Shezad Malik

There have been many reports of loosening and other failure problems with the Zimmer Persona artificial knee replacements.

According to sources, more than 11,600 of the “personalized” artificial knee components have been recalled less than three years after the novel design was introduced.

FDA Warning and Class 2 Recall

July 9, 2015

Texas Transvaginal Mesh Injury Settlement

by Dr. Shezad Malik

The massive transvaginal mesh injury lawsuits has been slowly winding its way through both the federal and state court system, over the past 4-5 years. The unwieldy personal injury and defective product liability litigation, which now by some estimates tops 100,000 filed lawsuits by injured and affected women, has been painstakingly slow.

The is a silver lining to the litigation. Recently, Medtronic’s Covidien unit agreed to settle more than 11,000 transvaginal mesh lawsuits filed by women who experienced serious and severe complications with the products.

What is Transvaginal Mesh and why is it Dangerous?

May 7, 2015

Texas Attorney Explains the Link Between Zofran and Birth Defects

by Dr. Shezad Malik

Zofran, is an anti-nausea medication that is commonly prescribed for post surgical, chemotherapy and morning sickness patients over the past 20 years. According to experts, recent medical studies have found pregnancy side effects that may increase the risk of severe and debilitating birth defects in children.

GlaxoSmithKline Allegations

Patients have blamed GlaxoSmithKline’s failure to adequately research their medication or warn about the risk of congenital malformations. Parents and injured children are filing Zofran birth defect lawsuits throughout the United States who have developed, Cleft Lip, Cleft Palate and severe Heart Defects, especially Atrial Septal Defect and Ventricular Septal Defect.

May 6, 2015

Texas Attorney Explains How Hysterectomy Can Lead to Cancer Spread

by Dr. Shezad Malik

Many product liability lawsuits being filed against the manufacturers of power morcellators. The injured women claim that patients and doctors should have been warned about the risks associated with use of the medical devices during minimally invasive, laparoscopic hysterectomies.

What Are Power Morcellators?

Power morcellators are medical devices that are used during laparoscopic hysterectomy and myomectomy procedures. The device allows the surgeon to grind up the uterus or uterine fibroids and remove the tissue through a small incision in the abdomen. The medical device is used during minimally invasive surgery, and reduces recovery time, scarring and speeds up recovery time.

May 1, 2015

Actos Attorney Explains Bladder Cancer Settlement

by Dr. Shezad Malik

It is official folks, Takeda Pharmaceutical Co. has announced this week, that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker agrees to settle more than 9,000 Actos bladder cancer lawsuits in federal and state courts in the U.S.

The settlement deal would average about $275,000 for each case, and would be the first settlement in the four year old litigation over the type 2 diabetes drug.

April 29, 2015

Nationwide Actos Bladder Cancer Settlement Confirmed

by Dr. Shezad Malik

Takeda Pharmaceutical Co. has announced today that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker agreed to settle more than 8,000 Actos bladder cancer lawsuits in federal and state courts in the U.S.

Any settlement deal would average about $275,000 for each case, and would be the first in the four year old litigation over the diabetes drug. The global settlement will be finalized at the next federal court hearing which is set for May 22.

Actos Settlement Details